Keyphrases
Academic Center
11%
Adverse Outcomes
11%
Bleeding
22%
Blood Product Transfusion
11%
By Stages
11%
Cardiac Surgery
100%
Cardiac Surgical Patients
11%
Dose Factor
100%
Early Administration
11%
Factor VIIa
100%
Group-based
11%
Increased Incidence
11%
Intensive Care Unit Stay
11%
Length of Stay
100%
Optimal Dosing
11%
Optimal Timing
11%
Outcome-based
11%
Postoperative Renal Function
11%
Re-exploration
11%
Recombinant Activated Factor VII (rFVIIa)
100%
Resuscitation
44%
Retrospective Observational Study
11%
Single Product
11%
Surgical Bleeding
33%
Tertiary Care
11%
Thrombosis
11%
Timing of Administration
22%
Transfusion
100%
Nursing and Health Professions
Adverse Outcome
25%
Bleeding
25%
Blood Clotting Factor 7
25%
Heart Surgery
100%
Hemostatic Agent
25%
Intensive Care Unit
25%
Kidney Failure
25%
Length of Stay
100%
Low Drug Dose
100%
Operative Blood Loss
75%
Resuscitation
100%
Tertiary Health Care
25%
Thrombosis
25%
Medicine and Dentistry
Adverse Outcome
25%
Bleeding
25%
Blood Product
25%
Factor VII
25%
Heart Surgery
100%
Hemostat
25%
Intensive Care Unit
25%
Low Drug Dose
100%
Observational Study
25%
Operative Blood Loss
75%
Renal Failure
25%
Resuscitation
100%
Tertiary Care
25%
Thrombosis
25%